US Drug Access Priority: Brown Study | AcademicJobs
Explore the Brown University study unpacking why US patients access new drugs faster than EU, Canada, Japan, Australia peers—submission strategies over review speeds.
No reviews yet. Be the first to rate Irene!
Irene Papanicolas is Provost's Professor of Health Services, Policy, and Practice at the Brown University School of Public Health, where she also serves as Director of the Center for Health System Sustainability. She joined Brown after serving as a faculty member at the London School of Economics. Papanicolas holds a PhD from the London School of Economics and Political Science, awarded in 2011. Her research focuses on comparative health systems, health care costs, and health systems performance assessment. She leads the International Collaborative on Costs, Outcomes and Needs in Care (ICCONIC), which brings together partners from North America, Europe, and the Pacific to analyze patterns of health service utilization, costs, and outcomes for high-need, high-cost patients. Papanicolas has authored publications in peer-reviewed journals and contributed to edited volumes and book chapters on the measurement of health system performance and international health system comparisons, with works published by Cambridge University Press and Open University Press. She teaches courses including Comparative Health Care Systems.
Papanicolas's work contributes to national policy insights through health system comparisons. Her professional email address is publicly listed on the Brown University School of Public Health website.
Explore the Brown University study unpacking why US patients access new drugs faster than EU, Canada, Japan, Australia peers—submission strategies over review speeds.